Valuate Health Consultancy
Consulting firm focused on market access and commercialization in healthcare. Provides market access strategy, health economics and outcomes research (HEOR) guidance, customer engagement design, and analytics-driven platforms to inform payer and provider access decisions. Works with client teams to develop and implement evidence, pricing, and engagement plans.
Industries
Nr. of Employees
small (1-50)
Valuate Health Consultancy
Products
Integrated communications analytics platform
Platform for integrated analysis to optimize communications and measure customer equity across channels.
Automated pull-through and physician prioritization tool
Automated secondary-analysis tool that targets, segments, and prioritizes physicians based on access dynamics and pull-through performance.
Evidence evaluation and gap assessment service
Assessment and prioritization of areas for evidence generation and development of value evidence strategies.
Rapid-response payer survey platform
Survey platform tailored to market access decision makers for rapid collection of payer insights.
Behavioral drivers insights service
Qualitative and quantitative insights to identify behavioral drivers affecting access opportunities and risks.
Integrated communications analytics platform
Platform for integrated analysis to optimize communications and measure customer equity across channels.
Automated pull-through and physician prioritization tool
Automated secondary-analysis tool that targets, segments, and prioritizes physicians based on access dynamics and pull-through performance.
Evidence evaluation and gap assessment service
Assessment and prioritization of areas for evidence generation and development of value evidence strategies.
Rapid-response payer survey platform
Survey platform tailored to market access decision makers for rapid collection of payer insights.
Behavioral drivers insights service
Qualitative and quantitative insights to identify behavioral drivers affecting access opportunities and risks.
Services
Advisory services to develop coverage, pricing, contracting, and access strategies across the product lifecycle.
Evidence audits, value messaging development, and prioritization for evidence generation to support payer and provider decision making.
Design of stakeholder engagement programs, field training, and communication strategies for payers and providers.
Opportunity assessments, pricing sensitivity analysis, campaign effectiveness measurement, and channel optimization.
Management of a compensated US-based healthcare executive research panel and coordination of surveys, interviews, and advisory boards.
Advisory services to develop coverage, pricing, contracting, and access strategies across the product lifecycle.
Evidence audits, value messaging development, and prioritization for evidence generation to support payer and provider decision making.
Design of stakeholder engagement programs, field training, and communication strategies for payers and providers.
Opportunity assessments, pricing sensitivity analysis, campaign effectiveness measurement, and channel optimization.
Management of a compensated US-based healthcare executive research panel and coordination of surveys, interviews, and advisory boards.
Expertise Areas
- Market access strategy
- Health economics and outcomes research (HEOR)
- Payer and provider engagement
- Pricing and contracting strategy
Key Technologies
- Advanced analytics and statistical modeling
- Survey and rapid-response market research platforms
- Segmentation and targeting algorithms
- HEOR/value evidence frameworks
News & Updates
Point-of-view document summarizing key takeaways from AMCP Nexus.
POV on creativity in market access.
POV on AI applications in market access.
Case study describing commercialization support for a startup biotech.
Analysis of policy change impacts on pharmaceutical market access.
Point-of-view document summarizing key takeaways from AMCP Nexus.
POV on creativity in market access.
POV on AI applications in market access.
Case study describing commercialization support for a startup biotech.
Analysis of policy change impacts on pharmaceutical market access.